Taro Pharmaceutical Indus... (TARO)

NYSE: TARO · Real-Time Price · USD

42.98

0.01 (0.02%)

At close: Jun 21, 2024, 7:59 PM

Taro Pharmaceutical Industries Cash Flow Statement

Financials in USD. Fiscal year is April - March.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016
Net Income	53.87M	25.45M	58.27M	-400.74M	244.55M	282.12M	210.08M	456.67M	541.27M
Depreciation & Amortization	31.09M	32.13M	25.91M	23.68M	21.38M	18.6M	16.5M	14.83M	14.85M
Stock-Based Compensation	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Working Capital	15.73M	-60.12M	-268.6M	433.89M	19.12M	64.9M	2.66M	-108.17M	-101.14M
Other Non-Cash Items	34.27M	-4.72M	12.96M	584K	-12.56M	-26.45M	-227K	273K	-53K
Deferred Income Tax	19.15M	16.8M	23.2M	-38.41M	7.58M	12.26M	56.01M	73.71M	-11.98M
Change in Working Capital	28.1M	-37.91M	-279.04M	460.66M	10.65M	37.18M	7.43M	-79.81M	-137.22M
Operating Cash Flow	132.39M	31.75M	-158.7M	45.77M	271.61M	323.71M	323.69M	437.54M	395.13M
Capital Expenditures	-54.22M	-17.85M	-12.04M	-17.14M	-28.39M	-30.68M	-29.54M	-35.76M	-19.11M
Cash Acquisitions	n/a	-1.98M	-91.87M	161K	n/a	3.67M	2.65M	8.43M	-166K
Purchase of Investments	-1.5M	-107.71M	-66.67M	-1.13B	-269.77M	-8.37M	-770.49M	-286.63M	-300.82M
Sales Maturities Of Investments	140.06M	866.45M	809.12M	1.22B	28K	296.19M	557.31M	196.17M	32K
Other Investing Acitivies	138.31M	-864.47M	-809.12M	-161K	-28K	-3.67M	-1.57M	10K	35.33M
Investing Cash Flow	84.34M	-125.56M	-170.58M	67.74M	-298.16M	257.14M	-241.64M	-117.78M	-284.73M
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	-24.93M	-24.2M	-26.98M	-88.85M	-106.99M	-294.9M	-9.45M
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	n/a	-24.93M	-24.2M	-26.98M	-88.85M	-106.99M	-294.9M	-15.34M
Financial Cash Flow	n/a	n/a	-24.93M	-24.2M	-26.98M	-588.85M	-106.99M	-294.9M	-15.34M
Net Cash Flow	208.41M	-96.64M	-354.04M	91.82M	-54.1M	-9.16M	-23.79M	23.64M	95.12M
Free Cash Flow	78.17M	13.9M	-170.74M	28.63M	243.21M	293.02M	294.15M	401.78M	376.02M